Near Infrared Multivariate Model Maintenance: The Cornerstone of Success

Note for Guidance on the Use of Near Infrared Spectroscopy by the Pharmaceutical Industry and the Data Requirements for New Submissions and Variations. CPMP/ QWP/3309/01 and EMEA/CVMP/961/01. The European Agency for the Evaluation of Medicinal Products (2003).

Guideline on the Use of Near Infrared Spectroscopy by the Pharmaceutical Industry and the Data Requirements for New Submissions and Variations. EMEA/CHMP/CVMP/ QWP/17760/ 2009 Rev 2. European Medicines Agency (2014).

Guidance for Industry: PAT—A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance. FDA, United States Food and Drug Administration, US Department of Health and Human Services, Rockville, USA (2004).

ICH, Pharmaceutical Development. ICH Harmonised Tripartite Guideline Q8 (R2) (2009). www.ich.org

ICH, Quality Risk Management. ICH Harmonised Tripartite Guideline Q9 (2005). www.ich.org

ICH, Pharmaceutical Quality System. ICH Harmonised Tripartite Guideline Q10 (2008). www.ich.org